ネクセラファーマ(株)【4565】の掲示板 2022/11/27〜2022/12/01

1265

kei***** 2022年12月1日 21:19

Preclinical pipeline programs
Program Compound Disorder(s) Company
M4 receptor orthosteric agonist Not disclosed
Not disclosed Schizophrenia
Not disclosed Sosei Heptares
Sumitomo Dainippon Pharma
Dual M1 and M4 receptor orthosteric agonist Not disclosed Schizophrenia, Alzheimer's disease psychosis Neurocrine Biosciences
M4 receptor positive allosteric modulator Not disclosed Schizophrenia, other neuropsychiatric disorders Addex Therapeutics